Hak-Kim Chan

Prof. Hak-Kim Chan

Sydney Pharmacy School, University of Sydney, Sydney, New South Wales, Australia
orcid

Biography

Hak-Kim Chan, Professor in Pharmaceutics, leads the Advanced Drug Delivery Group at Sydney Pharmacy School, University of Sydney, Australia. Chan graduated from the University of Sydney (Ph.D. 1988 and D.Sc. 2009) and was a postdoc at the University of Minnesota and a scientist at Genentech Inc. He is a pioneer in applying novel particle engineering processes, characterization techniques and computational modelling for powder aerosols and inhaler design. His work was published mostly in leading specialty journals for the niche audience of pharmaceutical aerosol formulation and drug delivery to the lungs. His basic research has contributed to the diagnosis and treatment of life-threatening respiratory diseases through drug delivery by inhalation aerosol technology, from bench to market, culminating in the successful development of the formulations for two pharmaceutical respiratory products (Aridol and Bronchitol, Pharmaxis Ltd) approved by the US FDA. Research income from national and international competitive sources >$20 million, including US FDA and NIH. In recognition of his lifetime contributions to aerosol science in medicine and pharmaceutical science, he was awarded the prestigious Career Achievement Award by the International Society of Aerosol Medicine in 2023 and the Nagai Distinguished Scientist Award by the Asian Federation for Pharmaceutical Sciences in 2025.

Affiliations

University of Sydney

Sydney, New South Wales, Australia

Sydney Pharmacy School

Honors and Awards

honor

Career Achievement Award

International Society of Aerosol Medicine, Gernsheim, Hesse, Germany

Lifetime contributions to aerosol science in medicine

Experience

No experience has been shared yet.